(DXC) DXC Technology - Ratings and Ratios
IT Services, Analytics, Cloud, Security, Insurance Platforms
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 40.9% |
| Value at Risk 5%th | 64.5% |
| Relative Tail Risk | -4.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.74 |
| Alpha | -47.70 |
| CAGR/Max DD | -0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.477 |
| Beta | 1.258 |
| Beta Downside | 1.473 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.55% |
| Mean DD | 31.37% |
| Median DD | 30.87% |
Description: DXC DXC Technology November 09, 2025
DXC Technology (NYSE:DXC) delivers end-to-end IT services across the United States, Europe, Australia and other international markets, operating through two primary segments: Global Business Services (GBS) and Global Infrastructure Services (GIS).
GBS focuses on analytics, software engineering, consulting and data-driven solutions that help clients modernize mission-critical applications, automate operations and accelerate digital transformation, with a particular emphasis on insurance platforms and banking-card/payment process services.
GIS provides cloud-migration, zero-trust security, managed IT outsourcing and hybrid-cloud orchestration, aiming to reduce total cost of ownership while delivering a “consumer-like” experience for enterprise IT environments.
Key recent metrics: FY 2023 revenue of roughly $20.5 billion, with GBS contributing about 55 % of total sales; operating margin compressed to ~2.5 % amid higher labor costs; and cloud-related services growing at an estimated 8 % YoY, outpacing the broader IT services sector’s ~5 % growth rate.
Sector drivers that will likely impact DXC’s outlook include sustained enterprise spending on digital transformation (projected to rise 4-6 % annually), increasing demand for zero-trust security architectures, and the macro-trend of cost-pressured organizations seeking outsourced hybrid-cloud management.
For a deeper, data-rich assessment of DXC’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (373.0m TTM) > 0 and > 6% of Revenue (6% = 762.8m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 1.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.38% (prev 7.75%; Δ -4.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.56b > Net Income 373.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.81b) to EBITDA (2.15b) ratio: 1.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (179.2m) change vs 12m ago -2.57% (target <= -2.0% for YES) |
| Gross Margin 22.27% (prev 24.31%; Δ -2.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 93.88% (prev 95.85%; Δ -1.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.89 (EBITDA TTM 2.15b / Interest Expense TTM 231.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.52
| (A) 0.03 = (Total Current Assets 5.44b - Total Current Liabilities 5.01b) / Total Assets 13.58b |
| (B) -0.23 = Retained Earnings (Balance) -3.16b / Total Assets 13.58b |
| (C) 0.07 = EBIT TTM 898.0m / Avg Total Assets 13.54b |
| (D) -0.39 = Book Value of Equity -4.04b / Total Liabilities 10.25b |
| Total Rating: -0.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 53.13
| 1. Piotroski 5.50pt |
| 2. FCF Yield 22.64% |
| 3. FCF Margin 9.57% |
| 4. Debt/Equity 1.53 |
| 5. Debt/Ebitda 1.31 |
| 6. ROIC - WACC (= 0.03)% |
| 7. RoE 11.98% |
| 8. Rev. Trend -91.23% |
| 9. EPS Trend -33.67% |
What is the price of DXC shares?
Over the past week, the price has changed by +7.44%, over one month by +10.25%, over three months by +8.20% and over the past year by -30.16%.
Is DXC a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 8
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the DXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.5 | -4.4% |
| Analysts Target Price | 14.5 | -4.4% |
| ValueRay Target Price | 12.5 | -17.5% |
DXC Fundamental Data Overview December 10, 2025
P/E Trailing = 7.1089
P/E Forward = 4.5767
P/S = 0.2022
P/B = 0.8006
P/EG = 0.28
Beta = 1.092
Revenue TTM = 12.71b USD
EBIT TTM = 898.0m USD
EBITDA TTM = 2.15b USD
Long Term Debt = 2.25b USD (from longTermDebt, last quarter)
Short Term Debt = 1.85b USD (from shortTermDebt, last quarter)
Debt = 4.69b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.81b USD (from netDebt column, last quarter)
Enterprise Value = 5.38b USD (2.57b + Debt 4.69b - CCE 1.89b)
Interest Coverage Ratio = 3.89 (Ebit TTM 898.0m / Interest Expense TTM 231.0m)
FCF Yield = 22.64% (FCF TTM 1.22b / Enterprise Value 5.38b)
FCF Margin = 9.57% (FCF TTM 1.22b / Revenue TTM 12.71b)
Net Margin = 2.93% (Net Income TTM 373.0m / Revenue TTM 12.71b)
Gross Margin = 22.27% ((Revenue TTM 12.71b - Cost of Revenue TTM 9.88b) / Revenue TTM)
Gross Margin QoQ = 15.28% (prev 24.41%)
Tobins Q-Ratio = 0.40 (Enterprise Value 5.38b / Total Assets 13.58b)
Interest Expense / Debt = 1.13% (Interest Expense 53.0m / Debt 4.69b)
Taxrate = 69.47% (91.0m / 131.0m)
NOPAT = 274.2m (EBIT 898.0m * (1 - 69.47%))
Current Ratio = 1.09 (Total Current Assets 5.44b / Total Current Liabilities 5.01b)
Debt / Equity = 1.53 (Debt 4.69b / totalStockholderEquity, last quarter 3.07b)
Debt / EBITDA = 1.31 (Net Debt 2.81b / EBITDA 2.15b)
Debt / FCF = 2.31 (Net Debt 2.81b / FCF TTM 1.22b)
Total Stockholder Equity = 3.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 373.0m / Total Assets 13.58b)
RoE = 11.98% (Net Income TTM 373.0m / Total Stockholder Equity 3.11b)
RoCE = 16.72% (EBIT 898.0m / Capital Employed (Equity 3.11b + L.T.Debt 2.25b))
RoIC = 4.02% (NOPAT 274.2m / Invested Capital 6.82b)
WACC = 3.99% (E(2.57b)/V(7.26b) * Re(10.65%) + D(4.69b)/V(7.26b) * Rd(1.13%) * (1-Tc(0.69)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.39%
[DCF Debug] Terminal Value 69.54% ; FCFE base≈1.16b ; Y1≈1.17b ; Y5≈1.27b
Fair Price DCF = 84.90 (DCF Value 14.78b / Shares Outstanding 174.1m; 5y FCF grow 0.69% → 3.0% )
EPS Correlation: -33.67 | EPS CAGR: -2.40% | SUE: 1.64 | # QB: 1
Revenue Correlation: -91.23 | Revenue CAGR: -6.63% | SUE: -0.06 | # QB: 0
EPS current Year (2026-03-31): EPS=3.13 | Chg30d=+0.031 | Revisions Net=+6 | Growth EPS=-8.8% | Growth Revenue=-1.4%
EPS next Year (2027-03-31): EPS=3.15 | Chg30d=+0.007 | Revisions Net=+0 | Growth EPS=+0.6% | Growth Revenue=-2.7%
Additional Sources for DXC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle